5714 views | 5 years ago
TruSight Oncology 500 is a next-generation sequencing tumor profiling assay that analyzes 523 genes for cancer-related biomarkers with FFPE samples. The assay supports the identification of DNA and...
1741 views | 5 years ago
Next-generation sequencing (NGS) is becoming commonplace when seeking a diagnosis for rare genetic disease. This can create a bottleneck when analyzing and interpreting the billions of base pairs and...
914 views | 5 years ago
Carlo B. Bifulco, MD provides his point of view on Comprehensive Genomic Profiling (CGP), as an approach for assessing biomarkers for therapy selection and clinical trial enrollment, and why he believes...
2178 views | 5 years ago
At Illumina, we are on a mission to bring genomics into the classroom. Since classrooms are currently at home, we are bringing the classroom to each of you. Dive into our Genomics 101: At Home series...
10218 views | 5 years ago
Illumina Field Applications Scientists review individual best practices and troubleshooting for the Illumina DNA Prep with Enrichment – Tagmentation protocol (formerly known as Nextera Flex for Enrichment)....
9747 views | 5 years ago
NextSeq™ 2000: because breakthrough science requires breakthrough innovation. To learn more about how NextSeq 2000 helps make breakthrough science possible, visit: www.Illumina.com/NextSeq2000 Designed...
764 views | 5 years ago
At Illumina, we are on a mission to bring genomics into the classroom. Since classrooms are currently at home, we are bringing the classroom to each of you. Dive into our Genomics 101: At Home series...
4223 views | 5 years ago
At Illumina, we are on a mission to bring genomics into the classroom. Since classrooms are currently at home, we are bringing the classroom to each of you. Dive into our Genomics 101: At Home series...